SE9702794D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9702794D0
SE9702794D0 SE9702794A SE9702794A SE9702794D0 SE 9702794 D0 SE9702794 D0 SE 9702794D0 SE 9702794 A SE9702794 A SE 9702794A SE 9702794 A SE9702794 A SE 9702794A SE 9702794 D0 SE9702794 D0 SE 9702794D0
Authority
SE
Sweden
Prior art keywords
new compounds
purinoceptor
transmembrane
processes
preparation
Prior art date
Application number
SE9702794A
Other languages
English (en)
Swedish (sv)
Inventor
Nicholas Kindon
Premji Meghani
Stephen Thom
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9702794A priority Critical patent/SE9702794D0/xx
Publication of SE9702794D0 publication Critical patent/SE9702794D0/xx
Priority to US09/155,091 priority patent/US6200981B1/en
Priority to DE69809242T priority patent/DE69809242D1/de
Priority to AT98934105T priority patent/ATE227276T1/de
Priority to EP98934105A priority patent/EP1000038B1/de
Priority to PCT/SE1998/001391 priority patent/WO1999005123A1/en
Priority to JP2000504122A priority patent/JP2001510833A/ja
Priority to AU83704/98A priority patent/AU8370498A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9702794A 1997-07-24 1997-07-24 New compounds SE9702794D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9702794A SE9702794D0 (sv) 1997-07-24 1997-07-24 New compounds
US09/155,091 US6200981B1 (en) 1997-07-24 1998-07-15 Pyrimidin derivatives
DE69809242T DE69809242D1 (de) 1997-07-24 1998-07-15 Neue pyrimidinderivate
AT98934105T ATE227276T1 (de) 1997-07-24 1998-07-15 Neue pyrimidinderivate
EP98934105A EP1000038B1 (de) 1997-07-24 1998-07-15 Neue pyrimidinderivate
PCT/SE1998/001391 WO1999005123A1 (en) 1997-07-24 1998-07-15 Novel pyrimidin derivatives
JP2000504122A JP2001510833A (ja) 1997-07-24 1998-07-15 新規なピリミジン誘導体
AU83704/98A AU8370498A (en) 1997-07-24 1998-07-15 Novel pyrimidin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702794A SE9702794D0 (sv) 1997-07-24 1997-07-24 New compounds

Publications (1)

Publication Number Publication Date
SE9702794D0 true SE9702794D0 (sv) 1997-07-24

Family

ID=20407823

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702794A SE9702794D0 (sv) 1997-07-24 1997-07-24 New compounds

Country Status (8)

Country Link
US (1) US6200981B1 (de)
EP (1) EP1000038B1 (de)
JP (1) JP2001510833A (de)
AT (1) ATE227276T1 (de)
AU (1) AU8370498A (de)
DE (1) DE69809242D1 (de)
SE (1) SE9702794D0 (de)
WO (1) WO1999005123A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2172939T3 (es) * 1997-11-21 2002-10-01 Astrazeneca Uk Ltd Nuevos compuestos que son antagonistas de receptores acoplados a proteina g de 7-transmembrana (tm) de p2-purinoceptores.
US7179481B2 (en) * 2002-09-19 2007-02-20 Kimberly-Clark Worldwide, Inc. Vaginal health products
US7056889B2 (en) 2002-12-16 2006-06-06 Kimberly-Clark, Worldwide, Inc. Compounds that bind P2Y2 or P2Y1 receptors
US7098189B2 (en) * 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
AP2007004244A0 (en) 2005-05-10 2007-12-31 Intermune Inc Method of modulating stress-activated protein kinase system
BRPI0611138A2 (pt) 2005-06-02 2010-08-17 Hoffmann La Roche compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de sst subtipo 5 e utilização dos compostos
EP2296653B1 (de) 2008-06-03 2016-01-27 Intermune, Inc. Verbindungen und verfahren zur behandlung von entzündungserkrankungen und fibrotischen erkrankungen
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6930196A (en) * 1995-09-12 1997-04-01 Bayer Aktiengesellschaft Uracil derivative

Also Published As

Publication number Publication date
EP1000038B1 (de) 2002-11-06
US6200981B1 (en) 2001-03-13
ATE227276T1 (de) 2002-11-15
AU8370498A (en) 1999-02-16
EP1000038A1 (de) 2000-05-17
DE69809242D1 (de) 2002-12-12
JP2001510833A (ja) 2001-08-07
WO1999005123A1 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
BR0015963A (pt) Compostos de uréia antagonistas receptor muscarìnico, composições farmacêuticas compreendendo tais compostos e método de preparação destes compostos
IT1304150B1 (it) Derivati di ammine cicliche che sono antagonisti di recettori ccr-3,composizioni farmaceutiche che li contengono, metodi per il loro
BR0010215A (pt) Derivados de indolina como antagonistas de progesterona
PT1009732E (pt) 1-amino-alquilciclo-hexanos antagonistas do receptor nmda
DK0856001T3 (da) Pyrimidinderivater som 5-HT2C-receptor-antagonister
NO996178D0 (no) 4-aminopyrrol(3,2-d)pyrimidiner som neuropeptid y- reseptorantagonister
SE9702651D0 (sv) Novel compounds
ATE386740T1 (de) Beta-3 adrenergische agonisten
BR9915403A (pt) Antagonistas receptores iii de 4-aroil-piperidin-ccr-3
NO993350L (no) Vitronectin-reseptor-antagonister
DK1068202T3 (da) 1-(-heteroarylpropyl- eller -prop-2-enyl)-4benzylpipderidiner som NMDA-receptor-antagonister
NO20020574D0 (no) Substituerte 1,5-dihydropyrrol-2-onderivater som er virksomme som NMDA-reseptorantagonister for behandlingen av smertetilstanden
TR200002896T2 (tr) Kalsilitik Bileşimler
ID26223A (id) Antagonis reseptor vitronektin
SE9702002D0 (sv) Novel compounds
ATE227276T1 (de) Neue pyrimidinderivate
ITMI962385A0 (it) Diaril-ciclometilenpirazoli farmacologicamente attivi procedimento per prepararli e composizioni farmaceutiche che li contengono
AU1908400A (en) Benzimidazole compounds that are vitronectin receptor antagonists
AU1356299A (en) New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
NO20020578D0 (no) Substituerte pyrrolidin-2,3,4-trion-3-oskimderivater som er nyttige som NMDA-reseptorantagonister
ID28811A (id) Antagonis reseptor vitronektin
AU3611099A (en) Oxindole derivatives used as neurokinin receptor antagonists
BG102229A (en) Endothelium receptor antagonists
HUP0002714A3 (en) Betha-amino and betha-azidocarboxylic acid derivatives, and pharmaceutical compositions containing them as endothelin receptor antagonists
ID24309A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin